↓ Skip to main content

Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women

Overview of attention for article published in Cochrane database of systematic reviews, September 2010
Altmetric Badge

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
160 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women
Published in
Cochrane database of systematic reviews, September 2010
DOI 10.1002/14651858.cd007063.pub2
Pubmed ID
Authors

Sharif I Ismail, Christine Bain, Suzanne Hagen

Abstract

Pelvic organ prolapse is common and can be detected in up to 50% of parous women although many are asymptomatic. Oestrogen preparations are used to improve vaginal thinning (atrophy). It is possible that oestrogens, alone or in conjunction with other interventions, might prevent or assist in the management of pelvic organ prolapse, for example by improving the strength of weakened supporting structures.

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Canada 1 <1%
Unknown 158 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 28 18%
Student > Master 20 13%
Student > Ph. D. Student 18 11%
Student > Doctoral Student 13 8%
Student > Postgraduate 13 8%
Other 43 27%
Unknown 25 16%
Readers by discipline Count As %
Medicine and Dentistry 80 50%
Nursing and Health Professions 17 11%
Engineering 7 4%
Social Sciences 6 4%
Agricultural and Biological Sciences 6 4%
Other 11 7%
Unknown 33 21%